Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies.
Lang H, Béraud C, Cabel L, Fontugne J, Lassalle M, Krucker C, Dufour F, Groeneveld CS, Dixon V, Meng X, Kamoun A, Chapeaublanc E, De Reynies A, Gamé X, Rischmann P, Bieche I, Masliah-Planchon J, Beaurepere R, Allory Y, Lindner V, Misseri Y, Radvanyi F, Lluel P, Bernard-Pierrot I, Massfelder T.
Lang H, et al. Among authors: game x.
Front Oncol. 2022 Aug 11;12:930731. doi: 10.3389/fonc.2022.930731. eCollection 2022.
Front Oncol. 2022.
PMID: 36033544
Free PMC article.